Niagen Bioscience (NAGE)

• Market cap: $367M
• 1 day: -2.76%
• 5 days: -3.17%
• 1 month: -10.37%
• 3 months: -30.71%
• 6 months: -51.89%
• Year to date: -26.72%
• 1 year: -39.74%
• 5 years: -48.6%
• 10 years: 2.23%
• Sector: Healthcare
• Industry: Biotechnology

About: Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

Employees: 117